Has Reagan Street, MD received payments from drug or device companies?

Yes. Drug and device makers reported $279,774 in general payments to Reagan Street, MD across 268 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reagan Street, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reagan Street, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reagan Street, MD

Gynecologic Oncology · Fort Worth, TXNPI 1487845673

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $248,913 of the $279,774 with a category attached, or 89.0%. GSK accounts for 75.0% of it on its own, with 16 other manufacturers making up the rest. Among gynecologic oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$279,774in general payments, 2019–2025

Across 268 payments — averaging $1043.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$210K
Tesaro, Inc.$52K
Myriad Genetic Laboratories, Inc.$17K
AbbVie$111
Intuitive Surgical$67
Clovis Oncology, Inc.$66
plus $381 from 11 others

What the payments were for

Consulting fees$12,6505%
Speaking & faculty fees$248,91389%
Travel & lodging$10,6114%
Food & beverage$7,4683%
Education$1330%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	145	$209,779
Tesaro, Inc.	70	$52,007
Myriad Genetic Laboratories, Inc.	30	$17,363
AbbVie	2	$111
Intuitive Surgical	2	$67
Clovis Oncology, Inc.	2	$66
Merck	3	$59
Genmab U.S., Inc.	3	$58
Novartis	3	$57
Ambu Inc.	1	$44
Karyopharm Therapeutics Inc.	1	$33
Daiichi Sankyo Inc.	1	$29
Foundation Medicine, Inc.	1	$26
Pacira Pharmaceuticals Incorporated	1	$23
Integra Lifesciences Corporation	1	$23
Eisai Inc.	1	$17
Baxter Healthcare	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ZEJULA$193,900
JEMPERLI$65,223
myRisk$8,878
myChoice CDx$6,196
PreciseTumor$1,700

How this compares

$279,774 in reported general payments places this provider in the 95th percentile of 135 gynecologic oncology providers in Texas.

See all gynecologic oncology providers in Texas →

Medicare billing

Part B allowed, 2024

$124,833

Medicare patients

130

Services billed

1,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LynparzaOlaparib	11	$186,296
Letrozole	28	$895
Megestrol Acetate	17	$771
Dexamethasone	34	$701
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$484
Lidocaine-PrilocaineLidocaine/Prilocaine	19	$378
Olanzapine	41	$375
Pregabalin	18	$321
Fluconazole	11	$246
Gabapentin	17	$181
Tramadol Hcl	38	$155
Prochlorperazine Maleate	17	$147
Ondansetron Hcl	17	$125
Sertraline Hcl	13	$29

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Fort Worth

Tiffany RedfernFort Worth$165K
Christopher LafargueFort Worth$26K
de Ette VasquesFort Worth$19K
Noelle ClovenFort Worth$18K
Graham BrownFort Worth$5K
Robert ColemanHouston$864K
Joseph de la GarzaSan Antonio$234K
Maurie MarkmanHouston$204K
Dustin MandersDallas$171K
Antonio Santillan-GomezSan Antonio$162K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →